Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Arin K Greene, M.D.

Co-Author

This page shows the publications co-authored by Arin Greene and Steven Fishman.
Connection Strength

4.125
  1. Vascular anomalies in 5,621 patients: guidelines for referral. J Pediatr Surg. 2011 Sep; 46(9):1784-9.
    View in: PubMed
    Score: 0.464
  2. Wilms tumor screening is unnecessary in Klippel-Trenaunay syndrome. Pediatrics. 2004 Apr; 113(4):e326-9.
    View in: PubMed
    Score: 0.277
  3. Parkes Weber syndrome with lymphedema caused by a somatic KRAS variant. Cold Spring Harb Mol Case Stud. 2021 12; 7(6).
    View in: PubMed
    Score: 0.236
  4. Arteriovenous malformation phenotype resembling congenital hemangioma contains KRAS mutations. Clin Genet. 2020 12; 98(6):595-597.
    View in: PubMed
    Score: 0.216
  5. Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations. Angiogenesis. 2019 11; 22(4):547-552.
    View in: PubMed
    Score: 0.202
  6. Sonographic screening for Wilms tumor in children with CLOVES syndrome. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.173
  7. Somatic MAP2K1 Mutations Are Associated with Extracranial Arteriovenous Malformation. Am J Hum Genet. 2017 Mar 02; 100(3):546-554.
    View in: PubMed
    Score: 0.169
  8. Bevacizumab and interferon reduce venous recanalization following sclerotherapy. J Pediatr Surg. 2016 Oct; 51(10):1670-3.
    View in: PubMed
    Score: 0.162
  9. Male genital lymphedema: clinical features and management in 25 pediatric patients. J Pediatr Surg. 2014 Nov; 49(11):1647-51.
    View in: PubMed
    Score: 0.141
  10. Abstract 63: expression of follicle-stimulating hormone receptor in vascular anomalies. Plast Reconstr Surg. 2014 Apr; 133(4 Suppl):1024.
    View in: PubMed
    Score: 0.139
  11. Abstract 75: expression of follicle-stimulating hormone receptor in vascular anomalies. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):86.
    View in: PubMed
    Score: 0.138
  12. Expression of follicle-stimulating hormone receptor in vascular anomalies. Plast Reconstr Surg. 2014 Mar; 133(3):344e-351e.
    View in: PubMed
    Score: 0.138
  13. Expression of androgen, estrogen, progesterone, and growth hormone receptors in vascular malformations. Plast Reconstr Surg. 2012 Jun; 129(6):919e-924e.
    View in: PubMed
    Score: 0.122
  14. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012 Feb; 68(2):198-201.
    View in: PubMed
    Score: 0.119
  15. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg. 2012 Jan; 23(1):149-52.
    View in: PubMed
    Score: 0.119
  16. Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations. Plast Reconstr Surg. 2011 Oct; 128(4):260e-269e.
    View in: PubMed
    Score: 0.117
  17. Primary lymphedema: clinical features and management in 138 pediatric patients. Plast Reconstr Surg. 2011 Jun; 127(6):2419-2431.
    View in: PubMed
    Score: 0.114
  18. Differential diagnosis of lower extremity enlargement in pediatric patients referred with a diagnosis of lymphedema. Plast Reconstr Surg. 2011 Apr; 127(4):1571-1581.
    View in: PubMed
    Score: 0.113
  19. Evaluation of terminology for vascular anomalies in current literature. Plast Reconstr Surg. 2011 Jan; 127(1):347-351.
    View in: PubMed
    Score: 0.111
  20. Expression of angiogenic and vasculogenic factors in human lymphedematous tissue. Lymphat Res Biol. 2011; 9(3):143-9.
    View in: PubMed
    Score: 0.111
  21. Metastatic neuroblastoma mimicking infantile hemangioma. J Pediatr Surg. 2010 Oct; 45(10):2045-9.
    View in: PubMed
    Score: 0.109
  22. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010 Apr; 125(4):1185-1194.
    View in: PubMed
    Score: 0.105
  23. Risk of vascular anomalies with Down syndrome. Pediatrics. 2008 Jan; 121(1):e135-40.
    View in: PubMed
    Score: 0.090
  24. Verrucous Venous Malformation-Subcutaneous Variant. Am J Dermatopathol. 2021 Dec 01; 43(12):e181-e184.
    View in: PubMed
    Score: 0.059
  25. Congenital Disseminated Pyogenic Granuloma: Characterization of an Aggressive Multisystemic Disorder. J Pediatr. 2020 11; 226:157-166.
    View in: PubMed
    Score: 0.053
  26. Surgical Management of Fibroadipose Vascular Anomaly of the Lower Extremities. J Pediatr Orthop. 2020 Mar; 40(3):e227-e236.
    View in: PubMed
    Score: 0.052
  27. Fibroadipose Vascular Anomaly in the Upper Extremity: A Distinct Entity With Characteristic Clinical, Radiological, and Histopathological Findings. J Hand Surg Am. 2020 Jan; 45(1):68.e1-68.e13.
    View in: PubMed
    Score: 0.050
  28. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. Am J Hum Genet. 2016 06 02; 98(6):1271.
    View in: PubMed
    Score: 0.040
  29. Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma. Am J Hum Genet. 2016 Apr 07; 98(4):789-95.
    View in: PubMed
    Score: 0.040
  30. Imaging features of kaposiform lymphangiomatosis. Pediatr Radiol. 2016 Aug; 46(9):1282-90.
    View in: PubMed
    Score: 0.040
  31. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015 Apr; 166(4):1048-54.e1-5.
    View in: PubMed
    Score: 0.037
  32. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol. 2014 Dec; 37(6):1476-81.
    View in: PubMed
    Score: 0.035
  33. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop. 2014 Jan; 34(1):109-17.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.